Should you stop psychiatric medication if you become pregnant?

The second line appears on the test before breakfast. You stare at it, then at the white bottle beside the kettle. Congratulations, fear, and a search box all arrive at once. By the time the toast burns, you’ve found one page saying your medication is dangerous and another saying stopping it is dangerous.

You’re not supposed to solve this with cold coffee and 19 open tabs.

The short answer is no: don’t stop a psychiatric medication simply because you learned you’re pregnant. The American College of Obstetricians and Gynecologists recommends against withholding or discontinuing mental health medication because of pregnancy or lactation status alone. That isn’t a declaration that every medicine is safe for every pregnancy. It’s a reminder that a decision has two sides.

The comparison isn’t medication versus nothing

People often imagine a clean scale. One side holds medication risk. The other side holds a perfectly well parent having a perfectly uncomplicated pregnancy without medication. Real decisions are less decorative.

The other side may include returning depression, panic, mania, psychosis, severe insomnia, obsessive symptoms, substance use, missed prenatal care, poor nutrition, or an inability to function safely. Untreated illness can affect you, the pregnancy, the postpartum period, relationships, work, and your ability to care for yourself. A medication’s possible risks matter. So do the risks of removing a treatment that has kept you well.

I’ll often ask what happened before the medication. Were there hospitalizations, suicide attempts, manic episodes, months lost to depression, or milder symptoms that responded to therapy? Did symptoms return during earlier tapers? How long have you been stable? The bottle’s name matters, but your history is not background scenery.

A 2020 systematic review and meta-analysis found that stopping antidepressants during pregnancy didn’t produce the same relapse pattern for everyone. In populations with severe or recurrent depression, discontinuation was associated with a clearly higher relapse risk. In milder or moderate groups, the estimate was less certain. That’s why the internet can’t give every person the same red or green light.

“Pregnancy category” was never a personal plan

Older letter categories made medication risk look like a tidy school grade. They didn’t show the quality of the evidence, the timing or dose, the condition being treated, or the risks of not treating it. Modern labeling uses narrative sections because pregnancy evidence is more complicated than an alphabet.

For some medicines, there is substantial pregnancy experience. For others, the evidence is smaller. Certain medications carry specific concerns that may make changing the plan important, especially before conception or early in pregnancy. Others may be continued with monitoring when the benefit is strong. The right answer depends on the exact drug, formulation, dose, timing, diagnosis, medical history, other medicines, and your preferences.

Don’t let the phrase “there’s a risk” end the conversation. Ask: What outcome? How large is the absolute risk? How certain is the evidence? Does timing matter? What happens if I continue, change, or stop? What would we monitor? Risk without a denominator is just anxiety wearing a lab coat.

Abrupt stopping can create its own emergency

Skipping tonight’s dose may feel like the fastest way to protect the pregnancy. Depending on the medication, sudden stopping can cause withdrawal, rebound symptoms, seizures, mood destabilization, insomnia, agitation, or a return of the illness being treated. Some medicines need gradual changes. Some require closer laboratory or symptom monitoring. A few situations need urgent specialist input.

If you already missed a dose, don’t panic and don’t automatically double the next one. Call the prescriber or pharmacist for medication-specific instructions. If you can’t reach the usual clinician, the medication label, pharmacy, obstetric office, or urgent medical service can help you decide what needs attention today.

Seek urgent help for suicidal thoughts with intent, inability to stay safe, severe confusion, hallucinations, dangerous agitation, days without sleep plus rising energy or reckless behavior, or another rapid psychiatric change. Call or text 988 in the United States for crisis support. Use 911 for immediate life-threatening danger.

Build one conversation, not three disconnected ones

Your psychiatric prescriber understands the illness and treatment history. Your obstetric clinician understands the pregnancy and medical context. A maternal-fetal medicine or reproductive psychiatry specialist may help when the medication, diagnosis, or history makes the decision more complex. You shouldn’t have to carry contradictory messages between offices like a nervous courier.

Ask the clinicians to coordinate. Bring the actual medication list, including nonpsychiatric prescriptions, over-the-counter products, vitamins, supplements, nicotine, cannabis, alcohol, and other substances. Include the dose, how you take it, when you last changed it, and what it helps. Don’t quietly delete something because you’re embarrassed. The interaction you omit may be the part everyone needed.

Also say whether the pregnancy was planned, how far along you may be, whether you’re breastfeeding another child, and what matters most to you. Some people prioritize avoiding a particular side effect. Others have lived through a severe relapse and place enormous value on stability. Shared decision-making isn’t the clinician handing you a brochure and backing slowly out of the room.

Use a short checklist while you wait

Today, write one page with five headings: medication and dose; condition being treated; benefits you’ve noticed; side effects or concerns; what happened during past changes. Add the first day of your last menstrual period if you know it and the date of the positive test. Then send a simple message: “I learned today that I’m pregnant. I take these medications and haven’t changed them. Please advise how soon we should review the plan and whether you want me to contact obstetrics or a specialist.”

While you wait, keep taking prescribed medication as directed unless a qualified clinician tells you otherwise. Avoid adding supplements marketed as “natural mood support.” Natural products can have active ingredients, interactions, contamination, and very little pregnancy evidence. A leaf on the label doesn’t make pharmacology leave the building.

If you’re planning pregnancy rather than looking at a surprise test, the same conversation can happen before conception. That gives everyone time to review whether the current treatment is still needed, whether a safer or better-studied option fits, how slowly any change should happen, and what early warning signs deserve action.

The postpartum plan belongs in the room now

Medication decisions shouldn’t stop at delivery. Sleep disruption, feeding plans, pain treatment, medical complications, and the postpartum period can change risk and medication choices. People with bipolar disorder or prior postpartum psychosis may face especially serious relapse risk after birth and need a clear prevention plan before the due date.

Ask who will monitor mood and sleep, how quickly you can reach care, what your partner or support person should watch for, and what happens if symptoms return. Put emergency numbers where somebody besides you can find them. Planning ahead isn’t pessimism. It’s how you keep a hard week from also becoming a scavenger hunt.

You don’t need to prove that medication is harmless. No meaningful medical decision is. You need a comparison that is honest about the medicine, honest about the illness, and specific to you.

Sources: American College of Obstetricians and Gynecologists, Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum, Clinical Practice Guideline Number Five (2023; clinical update 2025); Bayrampour and colleagues, antidepressant discontinuation and depression relapse during pregnancy systematic review and meta-analysis, Journal of Clinical Psychiatry (2020); Alcantarilla and colleagues, perinatal mood-disorder relapse risk systematic review, Archives of Women’s Mental Health (2023); U.S. Food and Drug Administration, pregnancy and lactation labeling and pregnancy exposure registry resources.